Cited by 170Reproductive Health and ContraceptionOvarian function and disordersHypothalamic control of reproductive hormones

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

Open access

Mulders, Titia M.T, Dieben, Thom O.M·2001·Fertility and Sterility

DOI 10.1016/s0015-0282(01)01689-2

Open this paper in CoChat — free account

Abstract

Objective To assess the effects of the combined contraceptive vaginal ring NuvaRing on ovarian function.Design Randomized, open-label, crossover study.Setting Clinical pharmacology unit.Participant(s) Sixteen healthy female volunteers.Intervention(s) Group 1: one cycle of combined oral contraceptive containing desogestrel (150 microg) and ethinyl estradiol (30 microg) (desogestrel/EE COC), followed by a NuvaRing treatment period. Group 2: NuvaRing treatment period followed by a cycle of desogestrel/EE COC.Main outcome measure(s) Follicular diameter, serum hormone concentrations (follicle-stimulating hormone, 17beta estradiol, luteinizing hormone, and progesterone), and endometrial thickness.Result(s) NuvaRing use for the recommended period of 3 weeks resulted in complete inhibition of ovulation, as assessed by vaginal ultrasound (follicular diameter) and by serum luteinizing hormone and progesterone concentrations. Inhibition of ovulation was maintained for an additional 2 weeks of NuvaRing use. Ovarian suppression between the groups was comparable. Furthermore, ovarian suppression after 3 weeks of NuvaRing use was comparable to that on day 21 of DGS/EE COC intake. NuvaRing was well tolerated.Conclusion(s) NuvaRing completely inhibited ovulation throughout the normal 3-week period and the extended period of use. Ovarian suppression was comparable to that with desogestrel/EE COC.

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(01)01689-2

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: The pharmacodynamics and efficacy of Implanon®
Croxatto, H. B., & Mäkäräinen, L. (1998) · Contraception · doi:10.1016/s0010-7824(98)00118-8 · Cited by 188
Retracted
Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring
Timmer, C. J., & Mulders, T. M. T. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039030-00005 · Cited by 262
Self-citation
Classification and comparison of oral contraceptives containing new generation progestogens
Newton (1995) · Human Reproduction Update · doi:10.1093/humupd/1.3.231 · Cited by 57
Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrel
Fotherby, K. (1995) · Contraception · doi:10.1016/0010-7824(94)00010-t · Cited by 57
Clinical experience and pharmacological effects of an oral contraceptive containing 20μg oestrogen
Fotherby, K. (1992) · Contraception · doi:10.1016/0010-7824(92)90151-i · Cited by 41

Show all 5 references

Sorted by citations

Implantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications
Stewart, S. A., Domínguez‐Robles, J., Donnelly, R. F., & Larrañeta, E. (2018) · Polymers · doi:10.3390/polym10121379 · Cited by 404
Examining menstrual tracking to inform the design of personal informatics tools
Epstein, D. A., Lee, N. B., Kang, J. H., Agapie, E., Schroeder, J., Pina, L. R., Fogarty, J., Kientz, J. A., & Munson, S. (2017) · Proceedings of the 2017 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3025453.3025635 · Cited by 346
Why consider vaginal drug administration?
Alexander, N. J., Baker, E., Kaptein, M., Karck, U., Miller, L., & Zampaglione, E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.025 · Cited by 269
Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring
Dieben, T. O. M., Roumen, F. J. M. E., & Apter, D. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02124-5 · Cited by 249
Self-citation
Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol
Bjarnadóttir, R. I., Tuppurainen, M. T., & Killick, S. R. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121103 · Cited by 162
Skin patch and vaginal ring versus combined oral contraceptives for contraception
Lopez, L. M., Grimes, D. A., Gallo, M. F., Stockton, L. L., & Schulz, K. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003552.pub4 · Cited by 151
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
Curtis, K. M., Nguyen, A. T., Tepper, N. K., Zapata, L. B., Snyder, E. M., Hatfield‐Timajchy, K., Kortsmit, K., Cohen, M. A., Whiteman, M. K., Contributors, et al. (2024) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7303a1 · Cited by 162
Extended Regimens of the Contraceptive Vaginal Ring
Miller, L., Verhoeven, C., & Hout, J. I. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000175144.08035.74 · Cited by 124
A Comparison Between the Vaginal Ring and Oral Contraceptives
Veres, S., Miller, L., & Burington, B. E. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000136082.59644.13 · Cited by 109
Nestorone®: clinical applications for contraception and HRT
Sitruk-Ware, R. L., Small, M., Kumar, N., Tsong, Y. Y., Sundaram, K., & Jackanicz, T. M. (2003) · Steroids · doi:10.1016/s0039-128x(03)00140-5 · Cited by 90
Contraceptive vaginal rings: a review
Brache, V., & Faúndes, A. (2010) · Contraception · doi:10.1016/j.contraception.2010.04.012 · Cited by 82
Current status of contraceptive vaginal rings
Brache, V., Payán, L. J., & Faúndes, A. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.037 · Cited by 80
A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation
Alzahrani, A. G., Nyavanandi, D., Mandati, P., Youssef, A. A. A., Narala, S., Bandari, S., & Repka, M. A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121951 · Cited by 73
Ovarian function with a novel combined contraceptive vaginal ring
Mulders, T. M. T. (2002) · Human Reproduction · doi:10.1093/humrep/17.10.2594 · Cited by 72
Self-citation
Review of the combined contraceptive vaginal ring, NuvaRing®
Roumen, F. J. M. E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1964 · Cited by 69
Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing
Roumen, F. J. M. E. (2002) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2002.11949331 · Cited by 68
Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing®)
Wieder, D. R. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s6162 · Cited by 64
Vaginal ring contraception
Kerns, J., & Darney, P. D. (2010) · Contraception · doi:10.1016/j.contraception.2010.07.008 · Cited by 58
No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception
Black, A., Guilbert, É., Costescu, D., Dunn, S., Fisher, W. A., Kives, S. L., Mirosh, M., Norman, W. V., Pymar, H. C., Reid, R. L., et al. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.10.005 · Cited by 63
Design and Characterization of a Novel Series of Geometrically Complex Intravaginal Rings with Digital Light Synthesis
Janusziewicz, R., Mecham, S. J., Olson, K. R., & Benhabbour, S. R. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000261 · Cited by 58
The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials
Roumen, F. J. M. E. (2007) · Contraception · doi:10.1016/j.contraception.2007.01.013 · Cited by 57
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women
Westhoff, C. L., Torgal, A. H., Mayeda, E. R., Petrie, K. A., Thomas, T. A., Dragoman, M. V., & Cremers, S. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.022 · Cited by 56
The combined contraceptive vaginal ring (NuvaRing®): First experience in daily clinical practice in The Netherlands
Roumen, F. J. M. E., ten Berg, M. O., & Hoomans, E. H. M. (2006) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180500389547 · Cited by 54
New delivery systems in contraception: vaginal rings
Johansson, E. D. B., & Sitruk-Ware, R. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.056 · Cited by 54
Pharmacokinetic evaluation of desogestrel as a female contraceptive
Grandi, G., Cagnacci, A., & Volpe, A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.844229 · Cited by 53
Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive
Elkind-Hirsch, K. E., Darensbourg, C., Ogden, B. W., Ogden, L. F., & Hindelang, P. (2007) · Contraception · doi:10.1016/j.contraception.2007.08.001 · Cited by 55
The contraceptive vaginal ring (NuvaRing®) and hemostasis: a comparative study
Magnúsdóttir, E. M., Bjarnadóttir, R. I., Onundarson, P. T., Guðmundsdóttir, B. R., Geirsson, R. T., Magnusdóttir, S. D., & Dieben, T. O. M. (2004) · Contraception · doi:10.1016/j.contraception.2003.12.010 · Cited by 52
Self-citation
The combined contraceptive vaginal ring (NuvaRing®) and lipid metabolism: a comparative study
Tuppurainen, M., Klimscheffskij, R., Venhola, M., & Dieben, T. O. M. (2004) · Contraception · doi:10.1016/j.contraception.2004.01.004 · Cited by 51
Self-citation
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study
Cagnacci, A., Ferrari, S., Tirelli, A., Zanin, R., & Volpe, A. (2009) · Contraception · doi:10.1016/j.contraception.2009.01.012 · Cited by 50
Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study
Duijkers, I. J. M., Klipping, C., Verhoeven, C., & Dieben, T. O. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh493 · Cited by 50
Self-citation
A comparative study on the effects of a contraceptive vaginal ring NuvaRing®and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function
Duijkers, I. J. M., Killick, S. R., Bigrigg, A., & Dieben, T. (2004) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180400007199 · Cited by 47
Self-citation
The contraceptive vaginal ring, NuvaRing ® , a decade after its introduction
Roumen, F. J. M. E., & Mishell, D. R. (2012) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2012.713535 · Cited by 44
Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review
Zapata, L. B., Steenland, M. W., Brahmi, D., Marchbanks, P. A., & Curtis, K. M. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.035 · Cited by 44
The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women
Massai, R., Mäkäräinen, L., Kuukankorpi, A., Klipping, C., Duijkers, I. J. M., & Dieben, T. O. M. (2005) · Human Reproduction · doi:10.1093/humrep/dei117 · Cited by 43
Self-citation
Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
Larsen, S. V., Köhler‐Forsberg, K., Dam, V. H., Poulsen, A. S., Svarer, C., Jensen, P. S., Knudsen, G. M., Fisher, P. M., Ozenne, B., & Frøkjær, V. G. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13211 · Cited by 42
Pregravid contraceptive use and fecundability: prospective cohort study
Yland, J. J., Bresnick, K. A., Hatch, E. E., Wesselink, A. K., Mikkelsen, E. M., Rothman, K. J., Sørensen, H. T., Huybrechts, K. F., & Wise, L. A. (2020) · BMJ · doi:10.1136/bmj.m3966 · Cited by 41
Novel drug delivery methods for improving efficacy of endometriosis treatments
Garzon, S., Laganà, A. S., Barra, F., Casarin, J., Cromi, A., Raffaelli, R., Uccella, S., Franchi, M. P., Ghezzi, F., & Ferrero, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1829589 · Cited by 42
Complete and robust ovulation inhibition with NuvaRing
Killick, S. R. (2002) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2002.11949330 · Cited by 39
The Optimization of an Intravaginal Ring Releasing Progesterone Using a Mathematical Model
Helbling, I. M., Ibarra, J. C. D., & Luna, J. A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1201-6 · Cited by 38
Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone
Hashim, H. A., Alsherbini, W., & Bazeed, M. F. (2011) · Contraception · doi:10.1016/j.contraception.2011.07.012 · Cited by 37
The ins and outs of drug-releasing vaginal rings: a literature review of expulsions and removals
Boyd, P., Merkatz, R. B., Variano, B., & Malcolm, K. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1798927 · Cited by 36
Hormonal contraception: recent advances and controversies
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.093 · Cited by 36
The combined contraceptive vaginal device (NuvaRing®): A comprehensive review
Sarkar, N. (2005) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180500131683 · Cited by 34
Contraception: an international perspective
Sitruk-Ware, R. L. (2005) · Contraception · doi:10.1016/j.contraception.2005.08.019 · Cited by 34
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women
Dragoman, M. V., Petrie, K. A., Torgal, A. H., Thomas, T. A., Cremers, S., & Westhoff, C. L. (2012) · Contraception · doi:10.1016/j.contraception.2012.12.001 · Cited by 33
Canadian Contraception Consensus
(2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30260-2 · Cited by 33
High acceptability and satisfaction with NuvaRing use
Szarewski, A. (2002) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2002.11949333 · Cited by 33
Mathematical modeling of drug delivery from torus-shaped single-layer devices
Helbling, I. M., Luna, J. A., & Cabrera, M. I. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.018 · Cited by 32
Development, Validation and Application of a Stability Indicating HPLC Method to Quantify Lidocaine from Polyethylene-co-Vinyl Acetate (EVA) Matrices and Biological Fluids
Bhusal, P., Sharma, M., Harrison, J., Procter, G., Andrews, G. P., Jones, D. S., Hill, A. G., & Svirskis, D. M. (2017) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmx043 · Cited by 32
Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women
van Rooij, K., Bloemers, J., de Leede, L., Goldstein, I., Lentjes, E. G. W. M., Koppeschaar, H. P. F., Olivier, B., & Tuiten, A. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.008 · Cited by 32
Clinically advancing and promising polymer-based therapeutics
Souery, W. N., & Bishop, C. J. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.044 · Cited by 31
Skin patch and vaginal ring versus combined oral contraceptives for contraception
Lopez, L. M., Grimes, D. A., Gallo, M. F., & Schulz, K. F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003552.pub3 · Cited by 31
In vivo assessment of NuvaRing® placement
Barnhart, K. T., Timbers, K., Pretorius, E. S., Lin, K., & Shaunik, A. (2005) · Contraception · doi:10.1016/j.contraception.2005.03.012 · Cited by 30
New Hormonal Contraceptives: A Comprehensive Review of the Literature
Forinash, A. B., & Evans, S. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1573.31950 · Cited by 29
The effect of different contraceptive methods on the vaginal microbiome
Bastianelli, C., Farris, M., Bianchi, P., & Benagiano, G. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1917373 · Cited by 28
Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy
Young, I. C., & Benhabbour, S. R. (2021) · Polymers · doi:10.3390/polym13152450 · Cited by 27
An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing®
Bruni, V., Pontello, V., Luisi, S. V., & Petraglia, F. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.02.001 · Cited by 27
Continuation and compliance of contraceptive use
Pinter, B. (2002) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/713604343 · Cited by 27
Contraceptive Vaginal Ring
Madden, T. E., & Blumenthal, P. D. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e318159c07e · Cited by 26
Delivery options for contraceptives
Sitruk-Ware, R. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03499-9 · Cited by 26
Mechanistic model of hormonal contraception
Wright, A. A., Fayad, G. N., Selgrade, J. F., & Olufsen, M. S. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007848 · Cited by 26
Skin patch and vaginal ring versus combined oral contraceptives for contraception
Lopez, L. M., Grimes, D. A., Gallo, M. F., & Schulz, K. F. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003552.pub2 · Cited by 25
A non-opioid analgesic implant for sustained post-operative intraperitoneal delivery of lidocaine, characterized using an ovine model
Svirskis, D. M., Procter, G., Sharma, M., Bhusal, P., Dravid, A., MacFater, W. S., Barazanchi, A. W. H., Bennet, L., Chandramouli, K., Sreebhavan, S., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120409 · Cited by 24
Drug delivery systems for oestrogenic hormones and antagonists: the need for selective targeting in estradiol-dependent cancers
Ameller, T., Legrand, P., Marsaud, V., & Renoir, J. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.05.006 · Cited by 24
Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring
Nguyen, B. T., & Jensen, J. T. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.948842 · Cited by 24
CONTRACEPTIVE APPLICATIONS OF ESTROGEN
Likis, F. E. (2002) · Journal of Midwifery & Women s Health · doi:10.1016/s1526-9523(02)00234-9 · Cited by 23
Contraception for College Students
Greydanus, D. E., Rimsza, M. E., & Matytsina, L. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2004.11.005 · Cited by 23
Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis
Picado, A. L., Ocamica, O. L., & Lete, I. (2017) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2017.1287351 · Cited by 23
Hormonal Contraception in Adolescents
Ornstein, R. M., & Fisher, M. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608010-00003 · Cited by 23
The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use
Carey, A. S., Chiappetta, L., Tremont, K., Murray, P. J., & Gold, M. A. (2007) · Contraception · doi:10.1016/j.contraception.2007.07.013 · Cited by 23
FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
(2019) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2018-chc · Cited by 27
Future developments in hormonal contraception
Johansson, E. D. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.059 · Cited by 22
Skin patch and vaginal ring versus combined oral contraceptives for contraception
Gallo, M. F., Grimes, D. A., & Schulz, K. F. (2003) · doi:10.1002/14651858.cd003552 · Cited by 22
Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use
Merki‐Feld, G. S., & Hund, M. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.524717 · Cited by 20
Review of the vaginal contraceptive ring (NuvaRing®)
Westhoff, C. L., & Shimoni, N. (2008) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118908786000370 · Cited by 18
“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review
Buggio, L., Lazzari, C., Monti, E., Barbàra, G., Berlanda, N., & Vercellini, P. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4448-z · Cited by 17
La contraception du post-partum : état des connaissances
Robin, G., Massart, P., Graizeau, F., & du Masgenet, B. G. (2008) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2008.02.023 · Cited by 16
A phenomenological-based model of the endometrial growth and shedding during the menstrual cycle
Arbeláez-Gómez, D., Benavides-López, S., Giraldo-Agudelo, M. P., Guzmán-Álvarez, J. P., Ramírez-Mazo, C., & Gómez-Echavarría, L. M. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110922 · Cited by 15
Intravaginal rings for continuous low-dose administration of cervical ripening agents
Wang, Y., Boyd, P., Hunter, A. J., & Malcolm, K. R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.053 · Cited by 15
Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach
Hashim, H. A. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2605-y · Cited by 15
Can drug release rate from implants be tailored using poly(urethane) mixtures?
Lowinger, M. B., Su, Y., Lu, X., Williams, R. O., & Zhang, F. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.067 · Cited by 14
Development of an intravaginal ring delivering simultaneously anastrozole and levonorgestrel: a pharmacokinetic perspective
Nave, R. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1622609 · Cited by 14
Matrix-based controlled release delivery of acyclovir from poly-(ethylene co-vinyl acetate) rings
Giannasca, N. J., Suon, J., Evans, A. C., & Margulies, B. J. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101391 · Cited by 14
Contraception during perimenopause
Kailas, N., Sifakis, S., & Koumantakis, E. (2005) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180400020861 · Cited by 12
Regulation of Female Fertility and Identification of Future Contraceptive Targets
Chengalvala, M., Meade, E. H., Cottom, J. E., Hoffman, W. H., Shanno, L. K., Wu, M. M., Gregory, S., & Shen, E. S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778559632 · Cited by 12
Advances in Female Hormonal Contraception
SHULMAN, L. P. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302040-00003 · Cited by 12
Menstrual manipulation: Options for suppressing the cycle
Hicks, C. W., & Rome, E. S. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09128 · Cited by 14
Contraceptive needs of the perimenopausal woman
Williams, J. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00017-7 · Cited by 11
Promoting the Safety and Use of Hormonal Contraceptives
Gardner, J. S., & Miller, L. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.53 · Cited by 11
Reversible female contraceptives: historical, current, and future perspectives
Barton, B. E., Erickson, J. A., Allred, S., Jeffries, J. M., Stephens, K. K., Hunter, M. I., Woodall, K. A., & Winuthayanon, W. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad154 · Cited by 12
Contraception hormonale en pratique hors dispositifs intra-utérins. RPC Contraception CNGOF
Robin, G., Plouvier, P., Delesalle, A.-S., & Rolland, A.-L. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.10.003 · Cited by 10
New contraceptive methods: update 2003
Pettinato, A. A., & Emans, S. J. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00002 · Cited by 10
Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases
Kumar, S. R., Mehta, C. H., & Nayak, U. Y. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200707122012 · Cited by 9
Gynecologic problems of the perimenopause: evaluation and treatment
Kaunitz, A. M. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00010-4 · Cited by 9
Hormonal contraception: Recent advances and controversies
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.019 · Cited by 9
Hormonal contraception: recent advances and controversies
(2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.08.012 · Cited by 8
Nondaily Contraceptive Options
Kottke, M., & Cwiak, C. A. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318181a7d9 · Cited by 8
Vaginal delivery of contraceptives
Sitruk-Ware, R. L. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.4.729 · Cited by 8
The Effect of Drug Content Reduction on the In Vitro and In Vivo Properties of Levonorgestrel-Releasing Intravaginal Rings
Nave, R., Jalkanen, T., Talling, C., Kaneko, M., Matsuki, S., & Höchel, J. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.11.009 · Cited by 7
Novedades en anticoncepción hormonal
de Castro, F. L., & Prieto, J. L. (2005) · Información terapéutica del Sistema Nacional de Salud · Cited by 7

Authors: Mulders, T. M. T., & Dieben, T. O. M.
Affiliations: Organon (Netherlands) (NL)
Corresponding author: Dieben, Thom O.M
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 2001-05
Volume: 75
Issue: 5
Pages: 865-870
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/s0015-0282(01)01689-2
OpenAlex: W2158600879
Cited by: 170
References: 5
Citations by year: 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 4 · 2018: 4 · 2017: 9 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 5 · 2012: 7
FWCI: 15.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 7696 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords: NuvaRing, vaginal ring, combined oral contraceptives, ovulation inhibition, ovarian suppression, desogestrel, ethinyl estradiol, follicle-stimulating hormone, luteinizing hormone, follicle size, endometrial thickness
MeSH terms: Adolescent, Adult, Contraceptive Devices, Female, Contraceptives, Oral, Synthetic, Endometrium, Ethinyl Estradiol, Female, Follicle Stimulating Hormone, Ovarian Follicle, Humans, Luteinizing Hormone, Ovulation, Progesterone, Time Factors, Ultrasonography, Vinyl Compounds, Desogestrel, Cross-Over Studies, Estradiol Congeners

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks